» Articles » PMID: 25010142

Propionibacterium Acnes Promotes Th17 and Th17/Th1 Responses in Acne Patients

Overview
Publisher Elsevier
Specialty Dermatology
Date 2014 Jul 11
PMID 25010142
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Propionibacterium acnes is a Gram-positive commensal bacterium thought to be involved in the pathogenesis of acne vulgaris. Although the ability of P. acnes in the initiation of pro-inflammatory responses is well documented, little is known about adaptive immune responses to this bacterium. The observation that infiltrating immune cells consist mainly of CD4(+) T cells in the perifollicular space of early acne lesions suggests that helper T cells may be involved in immune responses caused by the intra-follicular colonization of P. acnes. A recent report showing that P. acnes can induce IL-17 production by T cells suggests that acne might be a T helper type 17 (Th17)-mediated disease. In line with this, we show in this work that, in addition to IL-17A, both Th1 and Th17 effector cytokines, transcription factors, and chemokine receptors are strongly upregulated in acne lesions. Furthermore, we found that, in addition to Th17, P. acnes can promote mixed Th17/Th1 responses by inducing the concomitant secretion of IL-17A and IFN-γ from specific CD4(+) T cells in vitro. Finally, we show that both P. acnes-specific Th17 and Th17/Th1 cells can be found in the peripheral blood of patients suffering from acne and, at lower frequencies, in healthy individuals. We therefore identified P. acnes-responding Th17/Th1 cells as, to our knowledge, a previously unreported CD4(+) subpopulation involved in inflammatory acne.

Citing Articles

Skin microbiome and dermatologic disorders.

Scharschmidt T, Segre J J Clin Invest. 2025; 135(3).

PMID: 39895627 PMC: 11785926. DOI: 10.1172/JCI184315.


The Therapeutic Mechanisms of Huayu Quban Capsule in Treating Acne Vulgaris Are Uncovered Through Network Pharmacology and Molecular Docking.

Zhang L, Huang Y, Zhu W J Cosmet Dermatol. 2024; 24(1):e16632.

PMID: 39552028 PMC: 11743294. DOI: 10.1111/jocd.16632.


The Role of the Skin Microbiome in Acne: Challenges and Future Therapeutic Opportunities.

Niedzwiedzka A, Micallef M, Biazzo M, Podrini C Int J Mol Sci. 2024; 25(21).

PMID: 39518974 PMC: 11546345. DOI: 10.3390/ijms252111422.


Th Pathways in Immune-Mediated Skin Disorders: A Guide for Strategic Treatment Decisions.

Speeckaert R, Belpaire A, Lambert J, Speeckaert M, van Geel N Immune Netw. 2024; 24(5):e33.

PMID: 39513029 PMC: 11538609. DOI: 10.4110/in.2024.24.e33.


Effect of oral doxycycline, azithromycin and isotretinoin on haematological inflammatory markers and interleukin-17A levels in acne vulgaris: a single blinded randomised interventional study.

Agrawal A, Bhardwaj A, Singh S, Budania A, Bains A, Sharma S Arch Dermatol Res. 2024; 316(10):697.

PMID: 39417892 DOI: 10.1007/s00403-024-03434-x.